Meropenem/vaborbactam: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 37: | Line 37: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Latest revision as of 17:29, 18 March 2025
Meropenem/vaborbactam is a combination antibiotic used to treat complicated urinary tract infections (cUTI), including kidney infections. It contains meropenem, a carbapenem antibiotic, and vaborbactam, a beta-lactamase inhibitor. This combination is used to treat infections caused by certain bacteria that are resistant to meropenem alone.
Mechanism of Action[edit]
Meropenem works by inhibiting the formation of the bacterial cell wall, leading to cell death. Vaborbactam protects meropenem from degradation by certain enzymes (beta-lactamases) produced by bacteria, thereby enhancing the effectiveness of meropenem.
Uses[edit]
Meropenem/vaborbactam is used to treat complicated urinary tract infections, including pyelonephritis, caused by susceptible bacteria. It is also used to treat certain types of Klebsiella pneumoniae infections.
Side Effects[edit]
Common side effects of meropenem/vaborbactam include headache, diarrhea, and infusion site reactions. Serious side effects may include allergic reactions, seizures, and Clostridium difficile-associated diarrhea.
Drug Interactions[edit]
Meropenem/vaborbactam may interact with other medications, including valproic acid and probenecid.
Dosage and Administration[edit]
Meropenem/vaborbactam is administered intravenously. The dosage and duration of treatment depend on the type and severity of the infection.
Precautions[edit]
Before using meropenem/vaborbactam, patients should inform their healthcare provider if they have a history of allergies to beta-lactam antibiotics, kidney disease, or seizures.


